DK0460882T3 - Lipopeptiddeacylase - Google Patents

Lipopeptiddeacylase

Info

Publication number
DK0460882T3
DK0460882T3 DK91304976.3T DK91304976T DK0460882T3 DK 0460882 T3 DK0460882 T3 DK 0460882T3 DK 91304976 T DK91304976 T DK 91304976T DK 0460882 T3 DK0460882 T3 DK 0460882T3
Authority
DK
Denmark
Prior art keywords
enzyme
deacylase
lipid
cyclicpeptide
aculeacin
Prior art date
Application number
DK91304976.3T
Other languages
Danish (da)
English (en)
Inventor
Wu-Kuang Yeh
Adam Joseph Kreusman
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK0460882T3 publication Critical patent/DK0460882T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/78Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/78Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/80Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/814Enzyme separation or purification
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/814Enzyme separation or purification
    • Y10S435/815Enzyme separation or purification by sorption

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Prostheses (AREA)
  • External Artificial Organs (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
DK91304976.3T 1990-06-07 1991-06-03 Lipopeptiddeacylase DK0460882T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53439490A 1990-06-07 1990-06-07

Publications (1)

Publication Number Publication Date
DK0460882T3 true DK0460882T3 (da) 1996-08-26

Family

ID=24129856

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91304976.3T DK0460882T3 (da) 1990-06-07 1991-06-03 Lipopeptiddeacylase

Country Status (14)

Country Link
US (1) US5573936A (de)
EP (1) EP0460882B1 (de)
JP (1) JP2994486B2 (de)
KR (1) KR0169994B1 (de)
AT (1) ATE140728T1 (de)
CA (1) CA2043762C (de)
DE (1) DE69121018T2 (de)
DK (1) DK0460882T3 (de)
ES (1) ES2089133T3 (de)
GR (1) GR3021292T3 (de)
HU (1) HU215232B (de)
IE (1) IE75885B1 (de)
IL (1) IL98349A (de)
TW (1) TW197471B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743777B1 (en) 1992-03-19 2004-06-01 Eli Lilly And Company Cyclic peptide antifungal agents and process for preparation thereof
CN1161462C (zh) * 1996-03-08 2004-08-11 藤泽药品工业株式会社 环脂肽物的脱酰化方法
EP0933422A4 (de) * 1996-06-13 2005-02-02 Fujisawa Pharmaceutical Co Zyclische lipopeptid acylase
US6361988B1 (en) 1997-03-25 2002-03-26 California Institute Of Technology ECB deacylase mutants
US6153410A (en) * 1997-03-25 2000-11-28 California Institute Of Technology Recombination of polynucleotide sequences using random or defined primers
US5936074A (en) * 1997-04-17 1999-08-10 Eli Lilly And Company Teicoplanin deacylation process and product
US6323176B1 (en) 1998-02-25 2001-11-27 Eli Lilly And Company Cyclic peptide antifungal agents
CN1337968A (zh) 1998-12-09 2002-02-27 伊莱利利公司 蓝刺菌素环肽化合物的纯化
EP1156782B1 (de) 1999-03-03 2005-05-04 Eli Lilly And Company Echinocandin pharmazeutische zusammensetzungen
CN1345333A (zh) 1999-03-03 2002-04-17 伊莱利利公司 棘白菌素/糖类复合物
JP2002538097A (ja) 1999-03-03 2002-11-12 イーライ リリー アンド カンパニー 薬学的経口ecb処方物および組成物の作製方法
AU767956B2 (en) 1999-03-03 2003-11-27 Eli Lilly And Company Formation and anion-exchange of crystalline echinocandin ammonium salts
MXPA02000458A (es) * 1999-07-15 2002-07-02 Lilly Co Eli Proceso para la desacilacion de lipodepsipeptidos.
CA2394350A1 (en) * 1999-12-15 2001-06-21 Cubist Pharmaceuticals, Inc. Lipopeptides as antibacterial agents
EP1240182A2 (de) * 1999-12-15 2002-09-18 Cubist Pharmaceuticals, Inc. Daptomycin analoge und deren verwendung als antibakterielle verbindungen
EP2298790A1 (de) * 1999-12-15 2011-03-23 Cubist Pharmaceuticals, Inc. Daptomycin Analoge und deren Verwendung als antibakterielle Verbindungen
US6696412B1 (en) 2000-01-20 2004-02-24 Cubist Pharmaceuticals, Inc. High purity lipopeptides, Lipopeptide micelles and processes for preparing same
US20060014674A1 (en) 2000-12-18 2006-01-19 Dennis Keith Methods for preparing purified lipopeptides
BR0211761A (pt) * 2001-08-06 2007-01-09 Cubist Pharm Inc depsipeptìdeos e processos para preparar os mesmos
US6991800B2 (en) 2002-06-13 2006-01-31 Vicuron Pharmaceuticals Inc. Antifungal parenteral products
DE102004060750A1 (de) 2004-12-15 2006-07-13 Sanofi-Aventis Deutschland Gmbh Verfahren zur Deacylierung von Lipopeptiden
MX2011006803A (es) * 2008-12-22 2011-09-06 Cubist Pharm Inc Agentes antibacterianos novedosos para el tratamiento de infecciones gram positivas.
US9394340B2 (en) * 2009-03-24 2016-07-19 Cadila Healthcare Limited Purification process for lipopeptides
IN2015DN01633A (de) 2012-09-24 2015-07-03 Dsm Sinochem Pharm Nl Bv
KR101425108B1 (ko) * 2012-09-25 2014-07-31 동국제약 주식회사 탈아실화된 환상 리포펩티드의 제조방법
CN108410929B (zh) * 2018-05-30 2024-01-26 博瑞生物医药(苏州)股份有限公司 阿尼芬净前体的制备方法
CN109593809A (zh) * 2018-12-07 2019-04-09 成都雅途生物技术有限公司 一种固定化微生物酶转化棘白菌素b的方法
CN113215185B (zh) * 2021-04-22 2022-04-29 浙江工业大学 一种用于重组表达棘白菌素b脱酰基酶的重组基因序列

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1159450A (en) * 1979-12-13 1983-12-27 Manuel Debono Process for the preparation of derivatives of cyclic peptide nuclei

Also Published As

Publication number Publication date
HU911897D0 (en) 1991-12-30
IL98349A (en) 1995-05-26
GR3021292T3 (en) 1997-01-31
IL98349A0 (en) 1992-07-15
ATE140728T1 (de) 1996-08-15
EP0460882A2 (de) 1991-12-11
KR920000919A (ko) 1992-01-29
KR0169994B1 (ko) 1999-02-01
US5573936A (en) 1996-11-12
JPH04228072A (ja) 1992-08-18
DE69121018T2 (de) 1996-12-19
TW197471B (de) 1993-01-01
IE911939A1 (en) 1991-12-18
CA2043762C (en) 2001-05-29
JP2994486B2 (ja) 1999-12-27
HU215232B (hu) 1998-11-30
DE69121018D1 (de) 1996-08-29
HUT61587A (en) 1993-01-28
IE75885B1 (en) 1997-09-24
ES2089133T3 (es) 1996-10-01
EP0460882B1 (de) 1996-07-24
EP0460882A3 (en) 1992-04-22
CA2043762A1 (en) 1991-12-08

Similar Documents

Publication Publication Date Title
DK0460882T3 (da) Lipopeptiddeacylase
ATE171216T1 (de) Expression und reinigung von rekombinantem, löslichem gewebefaktor
DE69332879D1 (de) Technetium-99-markierte peptide zur visualisierung vom entzuendungen
PT1062325E (pt) Purificacao de preparacoes de virus
DK163520C (da) Substitueret androsta-1,4-dien-3,17-dioner, fremgangsmaade til fremstilling deraf, praeparater indeholdende saadanne forbindelser samt anvendelsen af disse til fremstilling af farmaceutiske praeparater
AU4052389A (en) Derivatized glass supports for peptide and protein sequencing
DK0464140T3 (da) Aktivt adhæsionspeptid
ES2179077T3 (es) Acido glutamico decarboxilasa clonada.
HUP0003513A2 (hu) Apoptózist indukáló monoklonális antitest
DK289285D0 (da) Thymopentin analoge
DE3865963D1 (de) Elektrophoretisches gel hoher aufloesung sowie methode zur abscheidung von serumproteinen.
NO952336L (no) Insulin analoger
FI953093A0 (fi) Menetelmiä, joilla voidaan havaita ja hoitaa yksilöitä, joilla on epänormaaleja soluja, jotka ekspressoivat HLA-A2/tyrosinaasi-peptidiantigeenejä
PT1107981E (pt) Sintese de analogos peptidicos ciclicos de anel modificado
GB9311454D0 (en) Pharmaceutical compositions
ES2195409T3 (es) Purificacion de moleculas.
AP9100296A0 (en) Peptides and analogues and mixtures thereof for detecting antibodies to HTLV-1 and HTLV11 viruses.
ITRM920809A1 (it) Interleuchina-6 mutante con attivita' biologica migliorata rispetto all'interleuchina-6 selvatica.
KR920011511A (ko) 항종양 면역증강효과가 있는 단백다당체(g 009)
SANTIS Spherical cap harmonic analysis of local gravity field
GLAVCHEVA On the Worth of Staiko Staikov's Collection in Historical Seismology
DK268889D0 (da) Cykliske d-cys6-peptidforbindelser, fremgangsmaader til fremstilling heraf samt farmaceutiske midler indeholdende disse
Lopez-Trascasa et al. Isolation and characterization of a biologically active C2 derived oligopeptide
DE69738945D1 (de) Rken
DE69001376D1 (de) Navigationshilfsvorrichtung und terrestrisches navigationssystem.